Bolt Biotherapeutics IPO

Bolt Biotherapeutics is a biotechnology company developing Boltbodyâ„¢ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.

Total Funding to Date$64.6MM
Register for Details

For more details on financing and valuation for Bolt Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Bolt Biotherapeutics Ticker Symbol


Bolt Biotherapeutics Stock Price

$1.45 as of 12/2/22